scholarly journals Lipophagy: A New Perspective of Natural Products in Type 2 Diabetes Mellitus Treatment

2021 ◽  
Vol Volume 14 ◽  
pp. 2985-2999
Author(s):  
Mingyue Huang ◽  
Xinyu Yang ◽  
Zhenzhen Wang ◽  
Jianglan Long ◽  
Aiting Wang ◽  
...  
Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 726-P
Author(s):  
KRISTINA YU-ISENBERG ◽  
GEOF D. GRAY ◽  
CATHERINE FOLEY ◽  
JONATHAN T. STOKES ◽  
ALAN SHIELDS ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 90-LB
Author(s):  
SANJAY K. BAJPAI ◽  
RADHIKA NAIR ◽  
TICH CHANGAMIRE ◽  
RICHARD SHEER ◽  
QIANQIAN WANG ◽  
...  

2021 ◽  
Vol 18 ◽  
Author(s):  
Elvan Wiyarta ◽  
Wismandari Wisnu

Background: Insulin has recently received special attention concerning its use in COVID-19 patients. Although controversial, insulin can be able to worsen the prognosis of COVID-19 patients with Type 2 Diabetes Mellitus (T2DM) through an inflammatory pathway. This uncertain aspect brings a new perspective related to insulin use in this pandemic era. Objective: We tried to collect and analyze various studies related to this issue to provide a complete picture of the prognosis of insulin use in COVID-19 patients with T2DM. Methods: We comprehensively searched PubMed, Cochrane CENTRAL, Embase, EBSCO CINAHL, MEDLINE, and grey literature databases for studies investigating the effect of insulin on COVID-19 outcomes, including mortality, hospitalization, disease progression, other prognostic surrogates. Records were screened against the eligibility criteria. Result: 2556 articles were retrieved and were screened. A total of 8 studies were included in the final analysis. There are no studies with solid evidence supporting the effect of insulin treatment on the worsening of the prognosis of COVID-19 patients with T2DM. Although several studies have shown that insulin is associated with a poor prognosis, most studies have not considered confounders. This certainly makes it challenging to analyze the effects of insulin independently. Conclusion: We propose that COVID-19 patients with T2DM continue to receive insulin, but with careful observation of the risk of disease progression.


JAMA Surgery ◽  
2015 ◽  
Vol 150 (10) ◽  
pp. 931 ◽  
Author(s):  
Anita P. Courcoulas ◽  
Steven H. Belle ◽  
Rebecca H. Neiberg ◽  
Sheila K. Pierson ◽  
Jessie K Eagleton ◽  
...  

2017 ◽  
Vol 39 (11) ◽  
pp. 2296-2310.e14 ◽  
Author(s):  
Edith M. Heintjes ◽  
Jetty A. Overbeek ◽  
Gillian C. Hall ◽  
Daniel Prieto-Alhambra ◽  
Francesco Lapi ◽  
...  

Author(s):  
Yannis V. Simos ◽  
Konstantinos Spyrou ◽  
Michaela Patila ◽  
Niki Karouta ◽  
Haralambos Stamatis ◽  
...  

2017 ◽  
Vol 39 (4) ◽  
pp. 759-770 ◽  
Author(s):  
Jetty A. Overbeek ◽  
Edith M. Heintjes ◽  
Daniel Prieto-Alhambra ◽  
Patrick Blin ◽  
Régis Lassalle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document